The cost of asthma control
Asthma care has advanced significantly. This is attributed to a better understanding of clinical disease phenotypes and overlapping molecular endotypes amenable to therapy. Despite improvements inasthma care, rates of asthma control remain suboptimal. Adult asthma rates in Asia are lower than that in...
Main Author: | Chotirmall, Sanjay Haresh |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/80789 http://hdl.handle.net/10220/42255 |
Similar Items
-
Aging and the microbiome: implications for asthma in the elderly?
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017) -
The costs of asthma disease on the healthcare system
by: Kerim Yesildag
Published: (2022-03-01) -
Transforming growth factor β and severe asthma: A perfect storm
by: Al-Alawi, Mazen, et al.
Published: (2017) -
Medical resource utilization and the associated costs of asthma in China: a 1-year retrospective study
by: Xueer Yang, et al.
Published: (2023-11-01) -
Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
by: A. Arrobas, et al.
Published: (2021-03-01)